Development, Validation, and Innovation in Ophthalmic Laser-Based Imaging
Year: 2020
Type: article
Abstract: In April 2019, the US Food and Drug Administration, in conjunction with 11 professional ophthalmic, vision science, and optometric societies, convened a forum on laser-based imaging. The forum brought together the Food and Drug Administration, clinicians, researchers, industry members, and other stakeholders to stimulate innovation and ensure that patients in the US are the first in the world to have access to high-quality, safe, and effective medical devices. This conference focused on the technology, clinical applications, regulatory issues, and reimbursement issues surrounding innovative ocular imaging modalities. Furthermore, the emerging role of artificial intelligence in ophthalmic imaging was reviewed. This article summarizes the presentations, discussion, and future directions.
Source: JAMA Ophthalmology
Authors: Frank Brodie, Michael Repka, Stephen Allan Burns, S. Grace Prakalapakorn, Christie Morse, Joel S. Schuman, Michael R. Duenas, Natalie Afshari, John S. Pollack, Jennifer E. Thorne, Albert Vitale, H. Nida Sen, David Myung, Mark S. Blumenkranz, Elmer Tu, Daniel X. Hammer, Michelle Tarver, Bradley Cunningham, Larry Kagemann, SriniVas Sadda, David Sarraf, Glenn J. Jaffe, Malvina Eydelman
Institutions: Duke University, Duke Medical Center, Stanford University, American Academy of Ophthalmology, American Academy of Optometry, American Glaucoma Society, American Optometric Association, American Society of Cataract and Refractive Surgery, United States Food and Drug Administration, Center for Devices and Radiological Health
Language: English
Topic: Retinal Imaging and Analysis
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Eye Institute
OpenAlex ID: W3105576824